Search

everythinglearnresearchcommunity

for

Search:↓

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Medical terms make new health issues seem more serious but don't affect views on well-known conditions.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Most tinea capitis cases in southern Taiwan were in adult women, mainly caused by Trichophyton violaceum.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.